Group/Variable | Negative ( n  = 24) | AL ( n  = 16) | PL ( n  = 17) |
---|---|---|---|
CH138 + (%) | 13.72 ± 14.91a | 8.89 ± 9.72a | 11.88 ± 15.34a |
Annexin V − /PI − (%) | 30.74 ± 12.92a | 39.05 ± 16.06a | 24.97 ± 16.01a |
Annexin V + /PI − (%) | 39.50 ± 14.48a | 37.03 ± 21.92a | 39.27 ± 19.64a |
ROS production (%) | 54.91 ± 22.92a | 68.20 ± 21.85a | 69.98 ± 15.39a |
Intensity of ROS production (MFI) | 2069 ± 1008a | 1603 ± 585.7b | 865.6 ± 447.3c |
S. aureus phagocytosis (%) | 63.23 ± 17.80a | 55.11 ± 20.88a | 58.84 ± 15.21a |
Intensity of S. aureus phagocytosis (MFI) | 219.8 ± 100.3a | 211.2 ± 80.77a | 104.2 ± 39.11b |
CD44 expression (MFI) | 22.03 ± 22.65a | 1.07 ± 0.18b | 1.03 ± 0.09b |
CD62L expression (MFI) | 13.45 ± 15.41a | 1.01 ± 0.00a | 1.01 ± 0.00a |
CD11b expression (MFI) | 755.8 ± 344.6a | 633.3 ± 555.0a | 843.7 ± 334.9a |